BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 31173781)

  • 1. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
    Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
    Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice.
    Xiao L; Dou W; Wang Y; Deng H; Xu H; Pan Y
    Biochem Pharmacol; 2023 Oct; 216():115752. PubMed ID: 37634598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
    Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
    BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-
    Guo S; Chen S; Ma J; Ma Y; Zhu J; Ma Y; Liu Y; Wang P; Pan Y
    Mediators Inflamm; 2019; 2019():5796491. PubMed ID: 31354386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of Escherichia coli Nissle 1917 on the intestinal barrier is mediated by inhibition of RhoA/ROCK2/MLC signaling via TLR-4.
    Xu H; Hou Q; Zhu J; Feng M; Wang P; Pan Y
    Life Sci; 2022 Mar; 292():120330. PubMed ID: 35051420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
    Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
    J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
    Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escherichia coli K12: An evolving opportunistic commensal gut microbe distorts barrier integrity in human intestinal cells.
    Bhat MI; Sowmya K; Kapila S; Kapila R
    Microb Pathog; 2019 Aug; 133():103545. PubMed ID: 31112772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Poria cocos ethanol extract on the intestinal barrier function and intestinal microbiota in mice with breast cancer.
    Jiang Y; Fan L
    J Ethnopharmacol; 2021 Feb; 266():113456. PubMed ID: 33039631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
    Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
    J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4-Dependent Claudin-1 Internalization and Secretagogue-Mediated Chloride Secretion Regulate Irinotecan-Induced Diarrhea.
    Wardill HR; Bowen JM; Van Sebille YZ; Secombe KR; Coller JK; Ball IA; Logan RM; Gibson RJ
    Mol Cancer Ther; 2016 Nov; 15(11):2767-2779. PubMed ID: 27550942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer Membrane Vesicles and Soluble Factors Released by Probiotic
    Alvarez CS; Badia J; Bosch M; Giménez R; Baldomà L
    Front Microbiol; 2016; 7():1981. PubMed ID: 28018313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretions of Bifidobacterium infantis and Lactobacillus acidophilus Protect Intestinal Epithelial Barrier Function.
    Guo S; Gillingham T; Guo Y; Meng D; Zhu W; Walker WA; Ganguli K
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):404-412. PubMed ID: 28230606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Supernatants from Escherichia coli Nissle 1917 and Faecalibacterium prausnitzii on Intestinal Epithelial Cells and a Rat Model of 5-Fluorouracil-Induced Mucositis.
    Wang H; Jatmiko YD; Bastian SE; Mashtoub S; Howarth GS
    Nutr Cancer; 2017; 69(2):307-318. PubMed ID: 28094590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
    Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
    J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.
    Ukena SN; Singh A; Dringenberg U; Engelhardt R; Seidler U; Hansen W; Bleich A; Bruder D; Franzke A; Rogler G; Suerbaum S; Buer J; Gunzer F; Westendorf AM
    PLoS One; 2007 Dec; 2(12):e1308. PubMed ID: 18074031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells.
    Noda S; Tanabe S; Suzuki T
    Mol Nutr Food Res; 2013 Nov; 57(11):2019-28. PubMed ID: 23868418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
    Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
    mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects resulting from oral administration of
    Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
    Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a combination of in vitro models to investigate the impact of chlorpyrifos and inulin on the intestinal microbiota and the permeability of the intestinal mucosa.
    Réquilé M; Gonzàlez Alvarez DO; Delanaud S; Rhazi L; Bach V; Depeint F; Khorsi-Cauet H
    Environ Sci Pollut Res Int; 2018 Aug; 25(23):22529-22540. PubMed ID: 29808406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.